Kazakhstan, Hong Kong ‘can build biotech unicorns by linking talent and capital’

Kazakhstan and Hong Kong could partner to build biotech unicorns – private start-ups valued at US$1 billion or more – by linking the Central Asian country’s strong tech workforce with the city’s global financial network, a top academic has said.
Huck-Hui Ng, dean of the school of medicine at Kazakhstan’s Nazarbayev University, said the nascent biotech sector in the country has already produced several start-ups in areas including artificial intelligence (AI) and digital health, and could build a...